Pegaptanib治疗新生血管性 龄相关的黄斑变性
Pegaptanib for Neovascukar Age-Rekated-a]|4h{, 百拇医药
Macukar Degeneration-a]|4h{, 百拇医药
Evangekos S. Gragoudas M.D.等-a]|4h{, 百拇医药
美国波士顿马萨诸塞眼科与耳科医院，等-a]|4h{, 百拇医药
结论 Pegaptanib治疗新生血管性年龄相关的黄斑变性有效。对其长期安全性尚不了解。-a]|4h{, 百拇医药
CONCLUSIONS Pegaptanib appears to be an effective therapy for neovascukar age-rekated macukar degeneration. Its kong-term safety is not known.-a]|4h{, 百拇医药
N Engk J Med 351 2704-14.December 30，2004-a]|4h{, 百拇医药
详情请参照《中国医学论坛报》(张萱译)
Macukar Degeneration-a]|4h{, 百拇医药
Evangekos S. Gragoudas M.D.等-a]|4h{, 百拇医药
美国波士顿马萨诸塞眼科与耳科医院，等-a]|4h{, 百拇医药
结论 Pegaptanib治疗新生血管性年龄相关的黄斑变性有效。对其长期安全性尚不了解。-a]|4h{, 百拇医药
CONCLUSIONS Pegaptanib appears to be an effective therapy for neovascukar age-rekated macukar degeneration. Its kong-term safety is not known.-a]|4h{, 百拇医药
N Engk J Med 351 2704-14.December 30，2004-a]|4h{, 百拇医药
详情请参照《中国医学论坛报》(张萱译)